throbber
BIOTECHNOLOGY PROCESSES
`Scale-up and Mixing
`
`Edited by
`
`CHESTER S. HO
`State University of New York at Buffalo
`Buffalo, N.Y.
`
`JAMES Y. OLDSHUE
`Mixing Equipment Company
`Rochester, New York
`
`American Institute of Chemical Engineers
`New York, New York
`
`PETITIONERS
`
`EXHIBIT NO. 1012 Page 1 of 5
`
`

`

`<24 %. J?
`& J?
`
`-a# ti
`
`t
`
`Copyright 1987
`American Institute of Chemical Engineers
`345 East 47th Street
`New York, New York 10017
`
`AlChE shall not be responsible for statements or opinions advanced in papers
`or printed in its publications.
`
`Library of Congress Cataloging-in-Publication Data
`
`Biotechnology processes.
`Includes index.
`1. Biochemical engineering—Congresses. 2. Bio­
`technology—Methodology—Congresses.
`I. Ho, Chester S.,
`. II. Oldshue, James Y. III. American
`1950-
`Institute of Chemical Engineers.
`660'.6
`1987
`TP248.3.B62
`ISBN 0-8169-0410-3
`
`87-14393
`
`MANUFACTURED IN THE UNITED STATES OF AMERICA
`
`PETITIONERS
`
`EXHIBIT NO. 1012 Page 2 of 5
`
`

`

`Modeling the Dynamic Behavior of Immobilized Cell/Enzyme Bioreactors
`
`TABLE 1
`Experimentally Determined Diffusivities of Some Fermentation Substrates and Products (X106 cm2/s).
`
`Type of experiment
`
`Glucose
`
`Lactose
`
`Nil^ CI
`
`Patulin
`
`6-MSA
`
`Cell-free beads
`
`With dead Cells
`
`With live Cells
`
`6.68
`6.68
`
`7.58
`
`6.4
`6.0
`
`7.2
`
`55
`
`45
`
`6.28
`
`5.03
`
`2.92
`
`1.95
`
`XVni' l t ) = Zv-C*) +
`
`"o
`
`1
`
`1
`
`n0
`
`"o
`= ZV-('/f) +
`
`1
`
`1
`ZDR n2 diR
`
`y(—)2
`„o n
`
`1
`
`1
`
`00
`
`i
`
`no 1
`
`.1 " 1 n
`
`and finally
`no
`ZVnC'/f) = ZVn(Of) +
`) Z(-)2 - Z(-)2
`2 ("7^"
`tDR K
`dtR
`00 1
`K
`Using the property Z(—)2 = T- and defining:
`6
`! n
`I\2
`
`"O
`
`^ =
`
`and
`
`s, = E(-):
`
`1 n
`
`6
`
`1 n
`
`dCb
`
`2 ^
`= ( j ) Z V n C )
`
`(A-13)
`
`Substitution in Eqn. A-l yields:
`
`D
`e — = £)(€.„ - CL) - 6(1 - e)(^-) 5>,(0(A-14)
`at
`V
`1
`A
`
`Evaluation of the infinite summation^ V«(0
`1
`
`f »
`
`. 1 x ^ 6
`
`(A-15)
`
`Equation A-12 can be written as
`d\if
`1
`n
`(—) —
`kn
`dt
`depend of the
`In Eqn. A-15, the dynamics of the functions
`value of the coefficient x = (!/£„) ; small values of x indicate
`that
`the
`functions V„(0
`follow
`the
`forcing
`function
`{\/kn)(d$ldt). It is therefore reasonable to assume that for
`x < x0, the v/s can be evaluated using the quasi-steady state
`approximation
`
`, . , 1 , d<|)
`
`or, using dimensionless quantities
`d§
`1
`("T^)
`E Dr n2 n2 ' dlR
`
`V«(fR) =
`
`(A-16)
`
`(A-17)
`
`The value of n0 is determined as the one corresponding to XQ:
`1
`ZDr K2 (no2)
`
`— Xo
`
`or
`
`1
`)a5
`1
`"0 = (—) (
`t DR XQ
`n
`It was found by numerical experimentation, that for values of Xo
`less than 0.01, the resulting response curves, for given DR were
`identical to five significant figures. Subsequently, a value of
`x0 = 0.01 was used in all the runs.
`
`After the above considerations, the infinite summation Zv* (') is
`i
`estimated as follows:
`
`Dispersal of Insoluble Fatty Acid Precursors
`in Stirred Reactors as a Mechanism
`to Control Antibiotic Factor Distribution
`
`FLOYD M. HUBER
`RICHARD L. PIEPER
`ANTHONY J. TIETZ
`Fermentation Technology Department
`Eli Lilly and Company
`Indianapolis, Indiana 46285
`
`Biosynthesis of factors in the A-21978C antibiotic complex was controlled by
`addition of appropriate fatty acid precursors. Toxicity associated with higher fatty
`acids was avoided by continuous addition of the fatty acid at a rate nearly equal to
`the uptake by the producing organism. Inability of the producing organism to assimilate
`a solid, insoluble long-chain fatty acid was overcome by dissolution of the acid in
`another substrate.
`
`Substance A21978C is a complex of antibiotics
`produced by Streptomyces roseosporus, having
`a common cyclic polypeptide nucleus and dif­
`ferent fatty acid side chains (JO (2)
`(Figure 1). Separation of the major factors
`CI, C2, and C3 revealed differences in both
`in vitro antibiotic activity and toxicology
`for the different naturally occurring com­
`pounds. Deacylation of the alkanoyl side
`chain, followed by reacylation with a series
`of fatty acids indicated the n-decanoyl sub­
`stitution at position R, resulted in the best
`therapeutic potential (3) (40 C5).
`The natural occurrence of the n-decanoyl
`factor, designated LY146032, was too low to
`
`permit isolation in sufficient quantity
`directly from fermentation broth (Table 1).
`
`In an attempt to produce LY146032 by
`fermentation, the addition of decanoic acid
`during the antibiotic production phase of
`the fermentation was proposed. Initial
`efforts in shaken cultures were unsuccessful
`due to either the toxicity or insolubility
`of the fatty acid. In this paper we will
`describe efforts to direct the biosynthesis
`of A21978C factors in continuously stirred
`reactors operating in a fed-batch mode.
`MATERIALS AND METHODS
`A mutant strain of Streptomyces
`roseosporus NRRL 11379 was used to inoculate
`50 ml of vegetative medium of the following
`composition: Trypticase soy broth
`(Baltimore Biological Laboratories,
`Baltimore, Maryland), 30 mg/ml; potato
`dextrin, 25 mg/ml. The inoculated medium was
`incubated for 48 hours at 30oC in a 250 ml
`Erlenmeyer flask on a shaker rotating through
`an arc of two inches in diameter at 250 RPM.
`One-half ml of the mature vegetative culture
`was dispensed into multiple containers and
`stored in the vapor phase of liquid nitrogen.
`One ml of the stored culture was used to
`inoculate 800 ml of the vegetative medium
`described above. The inoculated vegetative
`medium was incubated in a 2000 ml Erlenmeyer
`flask at 320C for 120 hours on a shaker
`
`249
`
`we obtain
`"o
`+ ^57 <^> <•" T> <A-18>
`»•<")"
`i
`i
`The concentration at the surface, <}i(0. can be expressed in terms
`of the bulk concentration CL{t) using the partition coefficient
`(p), namely (KO?) = CL )/p
`
`Hence Eqn. A-18 becomes:
`"o
`Zv* ('*) = !>„('«) +
`i
`i
`Subsequent substitution Eqn. A-19 into A-14 yields:
`*0
`
`l
`6 (3 e
`
`dtR
`
`(1 - -rf )(A-19)
`S,
`
`dCL
`dtR
`
`1 +
`
`i
`
`Cin - CL - 6ep(l - e ) DR
`EpO - £)
`SN
`0 -TT-)
`p £
`S,
`
`(A-20)
`
`TABLE 1
`Distribution of Naturally Occurring Factors in A21978C
`Fermentation
`
`The normalized form of Eqn. A-12 is:
`
`=- e (n n )2 Dr
`
`dtR
`
`+ (-^) {~T
`P
`dtR
`
`).
`
`n = 1,2,3,....no.
`(A-21)
`Solution by numerical integration of Equations A-20 and A-21
`yields the dynamic response of the reactor.
`
`% of Total
`A21978C
`Complex
`27.3
`40.1
`25.5
`
`A21978C
`Factor
`
`CI
`C2
`C3
`C5
`LY146032
`
`Concentration
`yg/ml
`77
`113
`72
`trace
`trace
`282
`Eli Lilly and Company, Indianapolis,
`Indiana.
`
`248
`
`BIOTECHNOLOGY PROCESSES
`
`BIOTECHNOLOGY PROCESSES
`
`PETITIONERS
`
`EXHIBIT NO. 1012 Page 3 of 5
`
`

`

`Dispersal of Insoluble Fatty Acid Precursors
`
`Floyd M. Huber, Richard L. Pieper, and Anthony |. Tietz
`
`rotating through an arc of two inches in
`diameter at 250 RPM. The entire contents of
`the two flasks (approximately 1400 ml after
`incubation) were used to inoculate 1900 liters
`of a secondary vegetative stage having the
`following composition (mg/ml): soybean flour,
`5.0; yeast extract (Difco Laboratories,
`Detroit, Michigan), 5.0; calcium gluconate.
`10.0; KC1, 0.2; MgSO^yHzO, 0.2; FeSOWHaO,
`0.004; Sag 471 antifoam (Union Carbide,
`Danbury, Connecticut). The potassium,
`magnesium, and ferrous salts were prepared
`separately as follows: 7.6 g FeSGi,*71120 was
`dissolved in 76 ml of concentrated HC1. 380 g
`of MgSOi, *71120 and 380 g of KC1 and deionized
`water were added to bring the total volume to
`3800 ml. The inoculated medium was incubated
`24 hours in a stainless steel vessel at 30oC.
`The vessel was aerated at 0.85 v/v/m and
`stirred with conventional agitators.
`The mature secondary seed (8.33% v/v)
`was used to inoculate a production medium of
`the following composition (mg/ml): soybean
`flour, 22.0; Fe(NHi4)2S0it*6H20, 0.66; glucose
`monohydrate, 8.25; Sag 471, 0.22; potato
`dextrin, 33.0; and molasses (blackstrap).
`2.75.
`Two types of stirred reactors were used.
`The smaller vessel, operated at 120 liters,
`was agitated with two conventional flat
`Rushton type impellers at relatively high
`power input. The larger vessel, operated at
`4550 liters, was equipped with impellers
`having curved paddles and was operated at
`relatively low power input. Air flow in both
`reactors was supplied at 0.5 v/v/m by large
`open tubes which were estimated to contribute
`very little to the overall mixing. Respira­
`tion rates were estimated by difference in
`inlet and exhaust gas concentration via a
`Perkin-Elmer mass spectrometer. Distribution
`of A21978C factors was estimated by high
`performance liquid chromatography as
`described previously C2).
`Examination of the batch fermentation
`medium suggested that the growth limiting
`nutrient was carbon in the form of carbohy­
`drate. It was then hypothesized that in a
`fed-batch operation a moderately toxic sub­
`strate, such as decanoic acid, could be fed
`continuously to the fermentation if the
`metabolic consumption rate exceeded the
`addition rate.
`Delivery of decanoic acid to the
`culture presented a problem. With a melting
`point of 340C the compound is a solid at the
`fermentation temperature of 30oC, and the
`
`compound has very low solubility in water.
`In order to avoid the obvious problems aris­
`ing in supplying a limiting nutrient as a
`solid phase, the substrate was dispensed to
`the stirred reactor as a five percent solu­
`tion dissolved in a fifty percent ethanol/
`water mixture. There was an immediate
`response in oxygen uptake to the onset of
`the decanoic acid feed, as illustrated in
`Figure 2. Also, a significant improvement
`in LY146032 concentration was immediately
`realized (Table 2).
`
`TABLE 2
`Distribution of A21978C Factors with Decanoic Acid Feed3
`
`% of Total
`A21978C
`Complex
`19.8
`29.9
`11.5
`5.2
`33.5
`
`A21978C
`Factor
`CI
`C2
`C3
`C5
`LY146032
`
`Concentration
`yg/ml
`72
`109
`42
`19
`122
`364
`(a) N-decanoic acid/ethanol/water 1:2:2 fed
`50 ml per hour to 120 L operating volume.
`Material balances suggested that only
`a small portion of the decanoic acid that
`was fed could be accounted for by incorpora­
`tion into the product. Thus, most of the
`fatty acid was apparently catabolized,
`presumably by the beta-oxidation pathway.
`In an attempt to increase the amount of
`decanoic acid available for the incorpora­
`tion, the concentration of fatty acid in the
`
`TABLE 3
`Distribution of A21978C Factors with Increased Decanoic Acid
`Feed3
`
`% of Total
`A21978C
`Complex
`10.4
`15.0
`8.5
`4.1
`62.1
`
`A21978C
`Factor
`CI
`C2
`C3
`C5
`LY146032
`
`Concentration
`yg/ml
`131
`189
`107
`52
`784
`1263
`(a) N-decanoic acid/ethanol/water 1:2:2 fed
`50 ml per hour to 120 L operating volume.
`
`feed was increased to twenty percent—the
`solubility limit of decanoic acid in aqueous
`ethanol. A significant increase in both the
`LY146032 and total yield was observed
`(Table 3).
`
`Although the fed-batch fermentation
`employing the fatty acid/ethanol/water addi­
`tion proved an effective method of directing
`the synthesis of the A21978C complex, the
`presence of the volatile alcohol presented
`both safety problems and uncertainties in
`quantitating the carbon balance. It was not
`known to what extent the producing organism
`could metabolize ethanol, since it was likely
`that much of the alcohol was escaping in the
`exit gases. Methyl oleate was identified in
`batch shaken cultures as a metabolizable,
`non-toxic and low volatile solvent. A mix­
`ture of equal volumes of methyl oleate and
`decanoic acid remained liquid at 30oC. The
`results of feeding the mixture of decanoic
`acid dissolved in methyl oleate on an equiva­
`lent basis to the previously used aqueous
`ethanol feed resulted in a slightly higher
`total yield with a similar concentration of
`the desired LY146032 (Table 4).
`
`TABLE 4
`Distribution of A21978C Factors in a Decanoic Acid/Methyl
`Oleate Fed Fermentation3
`
`% of Total
`A21978C
`Complex
`
`10.6
`13.1
`8.7
`4.7
`62.8
`
`A21978C
`Factor
`CI
`C2
`C3
`C5
`LY146032
`
`Concentration
`yg/mi
`154
`191
`127
`68
`913
`1453
`(a) N-decanoic acid/methyl 1:1 oleate fed
`13 ml per hour to 120 L operating volume
`
`SCALE-UP CONSIDERATIONS
`The initial scale-up of the process to
`a larger 6000 L pilot-scale stirred reactor
`did not produce equivalent LY146032 factor
`distribution (Table 5).
`
`The percentage of LY146032 was approxi­
`mately one-half of that obtained in the
`smaller equipment. It was hypothesized that
`the microbial population was oxidizing the
`decanoic acid preferentially over the methyl
`oleate, and due to the poorer mixing in the
`
`250
`
`BIOTECHNOLOGY PROCESSES
`
`BIOTECHNOLOGY PROCESSES
`
`TABLE 5
`Distribution of A21978C Factors with Decanoic Acid/Methyl
`Oleate Fed to a Larger Reactor3
`
`% of Total
`A21978C
`Complex
`17.0
`22.1
`17.7
`11.1
`32.0
`
`A21978C
`Factor
`CI
`C2
`C3
`C5
`LY146032
`
`Concentration
`yg/mi
`260
`337
`270
`170
`489
`1527
`(a) N-decanoic acid/methyl oleate 1:1 fed
`490 ml per hour to 4550 L operating
`volume
`
`large vessel, the uptake of the fatty acid
`was not equivalent throughout the population
`in the reactor (Table 6).
`
`TABLE 6
`Mixing Time and Power Input in Pilot-Scale Equipment Used in
`A21978C Fermentation
`(a)
`Power Input
`Vessel Size Mixing Time
`(Hp/100 Gal.)
`(Seconds)
`(1)
`1.36
`150
`7
`6000
`0.82
`43
`(a) Time required for pH to reach equilib­
`rium after addition of a sufficient
`quantity of 6M NaOH to increase pH by
`0.3
`The first approach to achieve better
`incorporation of the fatty acid precursor in
`the poorly mixed larger vessel was to
`increase the feed rate of the decanoic acid/
`methyl oleate mixture. The percentage of
`LY146032 increased to nearly that achieved
`in the smaller equipment, but the total yield
`of A21978C was reduced to about two-thirds of
`the amount achieved at the lower feed rate
`(Table 7).
`
`The reduction in overall yield associ­
`ated with the increased feed of the decanoic
`acid precursor was believed to be a result of
`the feed rate of the fatty acid approaching
`the metabolic rate of consumption. The con­
`sequences of introducing the toxic fatty acid
`
`251
`
`PETITIONERS
`
`EXHIBIT NO. 1012 Page 4 of 5
`
`

`

`D-Ala
`
`/
`1
`\
`
`L-Asp
`
`L-Orn
`
`Gly
`
`3-MeGlu (L-threo)
`
`Gly
`\
`D-Ser
`\
`/
`L-Kyn
`oy" 0 O
`
`.50
`
`| .40-
`IJ
`o
`E .30
`5
`a
`iS
`5. .20
`
`D s
`g .10
`x
`o
`
`Start
`Decanoic Acid
`Feed
`
`(
`
`15
`
`30
`
`45
`
`Hours
`
`60
`
`75
`
`FIGURE 3. The toxic effect of overfeeding decanoic acid.
`
`L-Asp
`
`L-Thr
`
`L-Asp
`
`L-Asn
`
`I
`t
`t
`t
`
`L-Trp
`
`NH
`/ w
`R 0
`
`Factor
`
`A21978Co
`A21978C,
`A21978C2
`A21978C3
`A21978C4
`A21978C5
`
`* mixture of two isomers
`
`R
`
`CJO alkanoyl*
`8-methyl decanoyl
`10-methyl undecanoyl
`10-methyl dodecanoyl
`0,2 alkanoyl t
`0,3 alkanoyl t
`t structure uncertain
`
`FIGURE 1. Naturally occurring A21978C factors.
`
`.50-
`
`X
`
`.40-
`
`Decanoic Acid
`Overfed
`
`-30-
`
`E

`9
`je
`a
`| .20-
`>
`X o
`
`.10-
`
`Feeder #1
`Feeder #2
`
`D
`D
`
`>JJ
`
`O
`O
`
`0.00
`0.00
`
`T
`15.00
`
`T
`T
`30.00
`45.00
`Hours
`
`T
`60.00
`
`75.00
`
`FIGURE 2. The effect of n-decanolc acid feed upon oxygen uptake.
`
`FIGURE 4. Feeding of n-decanolc acid/methyl oleate to a large reactor
`via two entry points.
`
`252
`
`BIOTECHNOLOGY PROCESSES
`
`BIOTECHNOLOGY PROCESSES
`
`Dispersal of Insoluble Fatty Acid Precursors
`
`Floyd M. Huber, Richard L. Pieper, and Anthony J. Tietz
`
`TABLE 7
`Distribution of A21978C Factors with Increased Decanoic Acid/
`Methyl Oleate Feda to a Larger Reactor
`
`A21978C
`Factor
`CI
`C2
`C3
`C5
`LY146032
`
`% of Total
`A21978C
`Complex
`11.9
`11.5
`8.1
`9.1
`59.4
`
`Concentration
`yg/ml
`122
`117
`83
`93
`607
`1022
`N-decanoic acid/methyl oleate 1:1 fed 590
`ml per hour to 4550 L operating volume
`
`(a)
`
`at a rate greater than the microbial consump­
`tion rate are illustrated in Figure 3. In
`this reactor the feeding system failed,
`resulting in significant overfeeding of the
`fatty acid. The resulting accumulation of
`the fatty acid caused rapid lysis of the
`culture as evidenced by the rapid cessation
`of respiration.
`A second approach to solve the mixing
`problem in the large fermenter was to intro­
`duce the fatty acid/ester mixture at two
`widely separated entry points. One entry
`point was at the top of the vessel and a
`second was in between the two impellers
`(Figure 4). The subsequent LY146032 concen­
`tration obtained (Table 8) indicated that a
`greater incorporation of the n-decanoyl side
`
`TABLE 8
`Distribution of A21978C Factors with Decanoic Acid/Methyl
`Oleate Fed to a Larger Reactor via Two Entry Points3
`
`% of Total
`A21978C
`Complex
`5.3
`8.5
`7.7
`1.1
`77.4
`
`A21978C
`Factor
`C1
`C2
`C3
`C5
`LY146032
`
`Concentration
`yg/ml
`75
`119
`108
`16
`1090
`1408
`(a) N-decanoic acid/methyl oleate 1:1 fed 212
`ml per hour to each of two entry points.
`4550 L working volume.
`
`chain had occurred as a result of the dual
`introduction.
`
`In summary, the following scale-up prob­
`lems associated with the production of
`LY146032 have been addressed and solved:
`A sound strategy was provided to
`feed the microbial culture a very toxic
`substance.
`A mechanism was devised to supply
`the normally solid substrate to the reactor
`in a convenient liquid form.
`Preferential substrate utilization
`was identified and the necessary feeding
`hardware was constructed to promote homogen­
`eous utilization of lipoidal materials when
`the fermentation was scaled up to larger
`reactors.
`
`LITERATURE CITED
`Hamill, R.L. and M.M. Hoehn, U.S. Patent
`4,208,403 to Eli Lilly and Company
`(June 17, 1980).
`Debono, Manuel, U.S. Patent 4,399,067 to
`Eli Lilly and Company (August 16, 1983).
`Debono, Manuel, B.J. Abbott, V.M.
`Krupinski, R.M. Molloy, D.J. Berry, F.T.
`Counter, L.C. Howard, J.L. Ott and R.L.
`Hamill, "Synthesis and Structure Activity
`Relationships of New Analogs of the New
`Gram Positive Lipopeptide Antibiotic
`A21978C," Abstract 1077, Interscience
`Conference on Antimicrobial Agents and
`Chemotherapy (ICAAC) (October 1984).
`Fukuda, D.S., B.J. Abbott, D.J. Berry,
`L.D. Boeck, Manuel Debono, R.L. Hamill,
`V.M. Krupinski and R.L. Molloy, "Deacy-
`latipn and Reacylation of A21978C,
`Acidic Lipopeptide Antibiotic: Prepara­
`tion of New Analogs," Abstract 1076,
`Interscience Conference on Antimicrobial
`Agents and Chemotherapy (ICAAC)
`(October 1984).
`Counter, F.T., P.J. Baker, L.D. Boeck,
`Manuel Debono, P.W. Ensminger, R.L.
`Hamill, V.M. Krupinski, R.M. Molloy and
`J.L. Ott, "LY146032 [N-(n-decanoyl)
`A21978C Nucleus], a New Acidic Lipopep­
`tide Antibiotic: Synthesis and Biological
`Evaluation," Abstract 1078, Interscience
`Conference on Antimicrobial Agents and
`Chemotherapy (ICAAC) (October 1984).
`
`!
`
`^ j
`
`PETITIONERS
`
`EXHIBIT NO. 1012 Page 5 of 5
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket